Genesis healthcare, inc. (GEN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities
Net income (loss)

7,474

-372,417

-959,204

-118,051

-526,768

-251,529

-176,970

-

-

-

-

Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-132,791

Net loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-390

Net income (loss)

-

-

-

-

-

-

-

21,597

-204,043

-1,840

-133,181

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Non-cash interest and leasing arrangements, net

27,311

72,193

77,974

90,227

93,800

86,073

89,141

-

-

-

-

Other non-cash gain, net

173,505

12,920

-8,473

202,070

1,063

-3,947

-2,853

-

-

-

-

Share based compensation

7,309

8,820

9,621

8,414

28,472

-

-

4,750

3,608

3,549

2,268

Depreciation and amortization expense

123,159

220,896

255,786

254,459

237,763

196,192

191,479

24,584

24,479

-

-

Reduction in the carrying amount of operating lease right-of-use assets

117,127

-

-

-

-

-

-

-

-

-

-

(Recovery) provision for losses on accounts receivable

-4,469

2,554

96,409

107,815

100,521

78,552

71,538

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-816

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

750

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

25,047

23,308

Provision for losses on accounts receivable

-

-

-

-

-

-

-

7,409

7,467

9,617

11,039

Equity in net income of unconsolidated affiliates

712

100

243

3,286

2,139

-416

-691

-

-

-

-

Benefit for deferred taxes

-179

-3,475

-12,128

7,142

164,750

-58,293

-25,693

-

-

-

-

Customer receivership and other related charges

-

-

90,864

-

-

-

-

-

-

-

-

Long-lived asset impairments

16,937

104,997

191,375

32,110

26,768

-

-

-

-

-

-

Goodwill and identifiable intangible asset impairments

-

3,538

360,046

3,321

1,778

-

-

-

-

-

-

Long-lived asset impairment

-

-

-

-

-

31,399

9,999

-

-

-

-

Gain on early extinguishment of debt

2,822

94

6,566

-13,174

-130

-1,133

-

-

-

-

-

Excess tax benefits from stock-based payment arrangements

-

-

-

-

-

-

-

-242

255

0

23

Loss (gain) on disposal of property and equipment

-

-

-

-

-

-

-

98

-434

2,243

61

Amortization of debt issuance costs

-

-

-

-

-

-

-

2,813

3,328

3,892

4,711

(Gain) loss on extinguishment of debt

-

-

-

-

-

-

-63

-

-

-

-

Tax benefit from reversal of accrual for uncertain tax positions

-

-

-

-

-

-

-

-

-

-

-2,828

Provision for deferred taxes

-

-

-

-

-

-

-

3,490

-11,086

-54

5,966

Amortization of discount on debt

-

-

-

-

-

-

-

906

605

465

107

Debt retirement costs

-

-

-

-

-

-

-

4,126

0

6,574

0

Impairment of long-lived assets

-

-

-

-

-

-

-

0

270,478

0

170,600

Changes in assets and liabilities:
Transaction costs

-

-

-

-

-

-

17,203

-

-

-

-

Accounts receivable

-45,745

-66,508

86,256

170,126

144,624

33,568

109,844

15,293

9,299

14,508

-15,836

Payments on notes receivable

-

-

-

-

-

-

-

3,116

3,314

4,846

5,464

Other current and non-current assets

-

-

-

-

-

-

-

1,952

-6,964

8,649

9,771

Accounts payable and other accrued expenses and other

-76,911

-71,916

94,304

45,232

29,230

53,330

46,095

-10,128

1,761

3,065

-2,111

Operating lease obligations

-93,630

-

-

-

-

-

-

-

-

-

-

Employee compensation and benefits

-

-

-

-

-

-

-

1,083

1,366

9,181

-1,597

Insurance liability risks

-

-

-

-

-

-

-

-1,637

-1,531

-4,390

-3,934

Other long-term liabilities

-

-

-

-

-

-

-

-3,148

1,040

839

1,190

Net cash (used in) provided by operating activities

-7,166

18,584

120,455

68,361

8,618

107,652

82,149

42,676

99,380

35,391

75,021

Cash flows from investing activities:
Capital expenditures

62,727

51,152

-

-

-

-

-

-

-

-

-

Capital expenditures

-

-

64,106

93,118

85,723

70,987

77,399

19,522

16,298

27,736

41,155

Purchases of marketable securities

70,316

79,650

48,595

52,554

83,916

30,449

39,569

-

-

-

-

Acquisitions

-

-

-

-

-

-

-

1,053

24,019

45,380

-

Cash paid for purchase of previously leased facilities

-

-

-

-

-

-

-

-

-

18,035

0

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

1,050

400

14,746

0

Proceeds on maturity or sale of marketable securities

71,174

69,180

69,273

72,767

41,314

30,188

26,227

0

-

-

-

Net change in restricted cash and equivalents

-

-

-

-22,183

-10,269

24,405

-4,235

-

-

-

-

Sale of investment in joint venture

-

-

-

6,460

26,358

-

-

-

-

-

-

Purchases of assets

591,660

-

-

108,299

167,272

1,878

12,200

-

-

-

-

Sales of assets

257,806

74,375

90,583

150,675

3,738

5,227

8,354

-

-

-

-

Restricted deposits

3,820

873

-

-

-

-

-

-

-

-

-

Notes receivable and other investment reductions

12,590

396

-

-

-

-

-

-

-

-

-

Other, net

50

400

-397

-3,107

-2,140

1,062

-4,832

-

-

-

-

Proceeds from the sale of home health agency

-

-

-

-

-

-

-

0

-

-

-

Acquisition of healthcare facilities and businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

5,013

Proceeds from the sale of home health agency

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the sale of land

-

-

-

-

-

-

-

0

-

-

-

Net cash (used in) provided by investing activities

-387,003

11,876

47,552

-12,788

-253,484

-95,675

-91,702

-19,525

-39,917

-76,405

-46,168

Restricted deposits

-

-

-

13,473

-

-

-

-

-

-

-

Investments in joint venture

-

-

-

536

392

2,309

6,182

-

-

-

-

Cash flows from financing activities:
Borrowings under revolving credit facilities

4,661,000

4,591,439

599,000

817,000

864,500

603,500

866,000

307,000

88,000

174,500

80,000

Repayments under revolving credit facilities

4,630,664

4,548,815

678,650

787,150

756,000

549,000

828,000

272,000

114,000

220,500

89,000

Repayments of long-term debt and capital leases

-

-

-

-

-

-

-

-

-

-

10,686

Proceeds from issuance of long-term debt

538,538

574,171

37,810

416,161

495,201

960

15,095

98,000

0

357,300

0

Proceeds from tenant improvement draws under lease arrangements

-

-

-6,084

-5,651

-2,920

-6,087

-

-

-

-

-

Proceeds from tenant improvement draws under lease arrangements

-

-

-

-

-

-

10,498

-

-

-

-

Repayment of long-term debt

199,626

544,077

128,307

500,101

357,716

17,946

35,085

165,423

21,201

259,322

-

Repayment of finance lease obligations

2,645

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

10,182

17,030

5,852

14,524

19,193

7,916

746

-

-

-

-

Debt settlement costs

-

485

-

-

-

-

-

-

-

-

-

Contributions from noncontrolling interests

27,031

-

-

-

-

-

-

-

-

-

-

Distributions to noncontrolling interests and stockholders

-

-

-

2,745

10,851

21,527

7,014

-

-

-

-

Distributions to noncontrolling interests and stockholders

5,753

2,025

2,914

-

-

-

-

-

-

-

-

Cash paid for financing costs

-

-

-

-

-

-

-

-4,266

0

-10,207

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

0

26

0

0

Excess tax benefits from stock-based payment arrangements

-

-

-

-

-

-

-

-242

255

0

-23

Taxes paid related to net share settlement of equity awards

-

-

-

-

-

-

-

234

718

93

101

Payment of financing costs

-

-

-

-

-

-

-

-

-

-

7,952

Net cash provided by financing activities

377,699

53,178

-172,829

-65,708

218,861

14,158

20,748

-37,165

-47,638

41,678

-27,762

Net (decrease) increase in cash, cash equivalents and restricted cash and equivalents

-16,470

83,638

-4,822

-10,135

-26,005

-

-

-

-

-

-

Cash, cash equivalents and restricted cash and equivalents:
Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

26,135

11,195

-14,014

11,825

664

1,481

Cash flows from discontinued operations

-

-

-

-

-

-

-

-

-

-

390

Supplemental cash flow information:
Interest paid

153,589

393,632

435,510

445,959

416,163

369,124

354,129

-

-

-

-

Net taxes paid

1,496

4,427

-861

-10,270

20,893

2,408

12,584

-

-

-

-

Non-cash investing and financing activities:
Finance lease obligations, net write-down due to lease activity

-

69,255

5,350

-

56,766

13,096

-54,626

-

-

-

-

Finance lease obligations, net write-down due to lease activity

930,110

-

-

-

-

-

-

-

-

-

-

Financing obligations reduced

-

-

-

257,101

-

-

-

-

-

-

-

Finance lease obligations, net write-down due to lease activity

-

-

24,046

-

83,989

80,284

43,934

-

-

-

-

Finance lease obligations, net write-down due to lease activity under ASC 840

-

-

-

70,997

-

-

-

-

-

-

-

Assets subject to finance lease obligations, net (gross-up) write-down due to lease activity

53,588

-

-

-

-

-

-

-

-

-

-

Assets subject to capital lease obligations, net (gross-up) write-down due to lease activity, under ASC 840

-

-50,321

-5,350

-

-

-

-

-

-

-

-

Operating lease obligations, net gross-up due to lease activity

2,916,017

-

-

-

-

-

-

-

-

-

-

Assets subject to operating leases, net (gross-up) due to lease activity

-2,523,708

-

-

-

-

-

-

-

-

-

-

Financing obligations, net write-down due to lease activity

-2,734,940

-168,993

-

-

-

-

-

-

-

-

-

Assets subject to financing obligations, net write-down due to lease activity

1,718,507

131,048

-

-

-

-

-

-

-

-

-

Assumption of long-term debt, net of reclass

-

-

-

4,772

436,887

-

-

-

-

-

-

Assets subject to financing obligations, net write-down (gross-up) due to lease activity

-

-

-24,046

40,876

-

-

-

-

-

-

-